RYEIX
Price
$368.05
Change
+$1.92 (+0.52%)
Updated
Aug 21 closing price
Net Assets
27.47M
VENAX
Price
$89.68
Change
-$0.06 (-0.07%)
Updated
Aug 21 closing price
Net Assets
12.38B
Interact to see
Advertisement

RYEIX vs VENAX

RYEIX vs VENAX Comparison Chart in %
View a ticker or compare two or three
VS
RYEIX vs. VENAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYEIX is a Hold and VENAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VENAX has more cash in the bank: 12.4B vs. RYEIX (27.5M). VENAX pays higher dividends than RYEIX: VENAX (2.40) vs RYEIX (1.88). RYEIX was incepted earlier than VENAX: RYEIX (28 years) vs VENAX (22 years). RYEIX (1.43) is less costly to investors than VENAX (0.09). RYEIX is a more actively managed with annual turnover of: 551.00 vs. VENAX (11.00). RYEIX has a lower initial minimum investment than VENAX: RYEIX (2500) vs VENAX (100000). RYEIX annual gain was more profitable for investors over the last year : 51.30 vs. VENAX (48.08). RYEIX (181.88) and VENAX (181.39) have equivalent 5 years return.
RYEIXVENAXRYEIX / VENAX
Total Expense Ratio1.380.091,533%
Annual Report Gross Expense Ratio1.430.091,589%
Fund Existence28 years22 years-
Gain YTD41.26442.55397%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets27.5M12.4B0%
Annual Yield % from dividends1.882.4079%
Returns for 1 year51.3048.08107%
Returns for 3 years49.2346.44106%
Returns for 5 years181.88181.39100%
Returns for 10 years84.5785.7499%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACMIX12.810.08
+0.63%
Absolute Capital Defender Institutional
UBVFX90.920.56
+0.62%
Undiscovered Managers Behavioral Val R6
DDDRX17.300.04
+0.21%
Nomura Wealth Builder R
SWASX7.26N/A
N/A
Schwab Global Real Estate
FSCRX26.55N/A
N/A
Fidelity Small Cap Discovery